ATE535530T1 - 7-substituierte camptothecin- und camptothecin- analoga und herstellungsverfahren dafür - Google Patents

7-substituierte camptothecin- und camptothecin- analoga und herstellungsverfahren dafür

Info

Publication number
ATE535530T1
ATE535530T1 AT04777076T AT04777076T ATE535530T1 AT E535530 T1 ATE535530 T1 AT E535530T1 AT 04777076 T AT04777076 T AT 04777076T AT 04777076 T AT04777076 T AT 04777076T AT E535530 T1 ATE535530 T1 AT E535530T1
Authority
AT
Austria
Prior art keywords
camptothecine
analogas
substituted
production process
compounds
Prior art date
Application number
AT04777076T
Other languages
English (en)
Inventor
Mansukh Wani
Govindarajan Manikumar
Michael Wall
Original Assignee
Res Triangle Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Triangle Inst filed Critical Res Triangle Inst
Application granted granted Critical
Publication of ATE535530T1 publication Critical patent/ATE535530T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04777076T 2003-06-27 2004-06-25 7-substituierte camptothecin- und camptothecin- analoga und herstellungsverfahren dafür ATE535530T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/606,795 US7067666B2 (en) 2003-06-27 2003-06-27 7-substituted camptothecin and camptothecin analogs and methods for producing the same
PCT/US2004/020388 WO2005009347A2 (en) 2003-06-27 2004-06-25 7-substituted camptothecin and camptothecin analogs and methods for preparing same

Publications (1)

Publication Number Publication Date
ATE535530T1 true ATE535530T1 (de) 2011-12-15

Family

ID=33540138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04777076T ATE535530T1 (de) 2003-06-27 2004-06-25 7-substituierte camptothecin- und camptothecin- analoga und herstellungsverfahren dafür

Country Status (7)

Country Link
US (2) US7067666B2 (de)
EP (1) EP1638978B1 (de)
JP (1) JP4990620B2 (de)
AT (1) ATE535530T1 (de)
AU (1) AU2004258864B2 (de)
CA (1) CA2530046A1 (de)
WO (1) WO2005009347A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071204B2 (en) * 2003-06-30 2006-07-04 Research Triangle Institute Camptothecin analogs having an E-ring ketone
TWI375678B (en) 2005-06-09 2012-11-01 Yakult Honsha Kk A method of preparation of a tricyclic ketone
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
HUE031374T2 (en) * 2007-10-16 2017-07-28 Bionumerik Pharmaceuticals Inc C10-substituted camptothecin analogs
CN110590796B (zh) * 2018-06-12 2022-07-15 青岛海洋生物医药研究院股份有限公司 喜树碱衍生物及其制备方法和应用
JP2022501432A (ja) * 2018-09-17 2022-01-06 キャンゲット バイオテクファーマ， エルエルシー ヒト疾患の治療のためのｆｌ１１８プラットフォーム位置７および９由来の類似体の組成、合成、処方および適用の問題
SG11202110922QA (en) 2019-04-26 2021-10-28 Immunogen Inc Camptothecin derivatives
TW202547842A (zh) * 2021-04-29 2025-12-16 愛爾蘭商艾伯維製造管理無限公司 抗c-Met抗體藥物結合物
CA3241157A1 (en) 2021-12-16 2023-06-22 Wei Zhou Camptothecin compound and conjugate thereof
WO2024078449A1 (en) 2022-10-09 2024-04-18 LaNova Medicines Limited Compounds, compositions and methods
KR20260020468A (ko) 2023-06-05 2026-02-11 장쑤 맵웰 헬스 파마수티컬 알앤디 컴퍼니, 리미티드 항-b7-h3 항체 또는 그 단편 및 b7-h3를 표적으로 하는 항체 약물 접합체(anti-b7-h3 antibody or fragment thereof, and antibody drug conjugate targeting b7-h3)
CN117777153A (zh) * 2023-12-19 2024-03-29 浙江工业大学 20(s)-10,11-二氟亚甲二氧基喜树碱衍生物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32518A (en) * 1861-06-11 Improvement in city railroads
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS57116076A (en) * 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS5839685A (ja) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体及びその製造法
US4473692A (en) * 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS5839683A (ja) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
CH650768A5 (de) * 1982-08-27 1985-08-15 Pharmaton Sa Basische acetanilide, verfahren zu deren herstellung und arzneimittel, die diese acetanilide enthalten.
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US5122526A (en) 1987-03-31 1992-06-16 Research Triangle Institute Camptothecin and analogs thereof and pharmaceutical compositions and method using them
US5053512A (en) * 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5227380A (en) 1987-03-31 1993-07-13 Research Triangle Institute Pharmaceutical compositions and methods employing camptothecins
US5049668A (en) 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
US5340817A (en) 1987-04-14 1994-08-23 Research Triangle Institute Method of treating tumors with anti-tumor effective camptothecin compounds
US5122606A (en) 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US5180722A (en) 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
JPH0766265B2 (ja) * 1988-06-21 1995-07-19 株式会社河合楽器製作所 演奏情報処理装置の割込処理制御部
WO1991004260A2 (en) * 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
ZA911046B (en) * 1990-02-26 1992-10-28 Squibb & Sons Inc Quinoline and pyridine anchors for hmg-coa reductase inhibitors
US5496830A (en) * 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
US5614529A (en) 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
JP3499246B2 (ja) * 1995-11-02 2004-02-23 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド カンプトテシン誘導体の製造法
AU7732996A (en) * 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
KR100516593B1 (ko) * 1996-08-19 2005-09-22 바이오누머릭 파마슈티칼스, 인코포레이티드 고 친유성 캠프토테신 유도체
US6169080B1 (en) * 1997-02-13 2001-01-02 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
ES2262223T3 (es) * 1997-02-14 2006-11-16 Bionumerik Pharmaceuticals, Inc. Derivados de camptotecina altamente lipofilos.
US6825206B1 (en) * 2000-11-16 2004-11-30 Research Triangle Institute Camptothecin compounds with a thioether group
US6653319B1 (en) * 2001-08-10 2003-11-25 University Of Kentucky Research Foundation Pharmaceutical formulation for poorly water soluble camptothecin analogues

Also Published As

Publication number Publication date
AU2004258864B2 (en) 2009-08-20
US20050209263A1 (en) 2005-09-22
JP4990620B2 (ja) 2012-08-01
WO2005009347A3 (en) 2005-06-02
JP2007522083A (ja) 2007-08-09
EP1638978B1 (de) 2011-11-30
WO2005009347A2 (en) 2005-02-03
US20040266803A1 (en) 2004-12-30
US7067666B2 (en) 2006-06-27
EP1638978A2 (de) 2006-03-29
CA2530046A1 (en) 2005-02-03
AU2004258864A1 (en) 2005-02-03
EP1638978A4 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
NO20075142L (no) krystallformer av asenapinmaleat
GEP20247679B (en) Bicyclic heterocycles as fgfr inhibitors
WO2004071975A3 (en) Methods of making glass- ceramic particles
NO20076651L (no) Fremgangsmate for fremstilling av 2-metyl-l-(2-metylpropyl)-1H-imidazo[4,5-c] [1,5]naftyridin-4-amin
ATE535530T1 (de) 7-substituierte camptothecin- und camptothecin- analoga und herstellungsverfahren dafür
EP2281841A3 (de) Biomarker zur Vorauswahl von Patienten für eine Anti-IGF1R Therapie
IL182872A0 (en) Ascomycin crystalline forms and preparation thereof
WO2004089947A3 (de) Neue verbindungen mit antibakterieller aktivität
WO2006098961A3 (en) Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
MXPA06001134A (es) Inhibidores de la actividad de la proteina cinasa b.
DE60312701D1 (de) Darstellung von 1h-imidazoä4,5-cüchinolin-4-aminen über neue 1h-imidazoä4,5-cüchinolin-4-cyano- und 1h-imidazoä4,5-cüchinolin-4-carboxamid intermediate
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
MA29935B1 (fr) Inhibiteurs de l'activite de akt
TW200621256A (en) Formulations
WO2007044050A3 (en) 1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
NO20072473L (no) Fremgangsmate for fremstilling av kinolinforbindelser og oppnadde produkter
TNSN06321A1 (en) Beta-carbolines useful for treating inflammatory disease
WO2005105753A3 (en) Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
TW200745137A (en) Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
WO2005001039A3 (en) Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof
DE60022095D1 (en) Camptothecin-beta-alanin-ester mit topoisomerase i hemmung
IS8416A (is) Aðferð við framleiðslu á CCR-2 mótlyfi
WO2004034985A3 (en) Chemical compounds
ATE281455T1 (de) Oxindolderivate